Utah Medical Products, Inc. (UTMD)

Market Cap	212.88M +18.9%
Revenue (ttm)	37.53M -4.4%
Net Income	10.85M -16.3%
EPS	3.38 -10.6%
Shares Out	3.18M
PE Ratio	19.76
Forward PE	n/a
Dividend	$1.24 (1.86%)
Ex-Dividend Date	Jun 17, 2026

Volume	1,373
Open	68.01
Previous Close	66.82
Day's Range	66.86 - 68.01
52-Week Range	52.00 - 71.81
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 23, 2026

About UTMD

Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK fee...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1978
• Employees: 152
• Stock Exchange: NASDAQ
• Ticker Symbol: UTMD
• Website: https://www.utahmed.com

Financial Performance

In 2025, Utah Medical Products's revenue was $38.52 million, a decrease of -5.83% compared to the previous year's $40.90 million. Earnings were $11.29 million, a decrease of -18.65%.